术后[68Ga]Ga-DOTA-TATE PET/CT对WHO 1级脑膜瘤无进展生存期的预后价值
本研究对46例49个WHO 1级脑膜瘤术后患者进行事后分析,患者接受术后MRI和[68Ga]Ga-DOTA-TATE PET/CT并定期MRI随访。中位随访52个月,7/49(14%)出现局部进展,PET阳性与进展风险增加和无进展生存期降低相关,而MRI无此关联,PET阴性者均无复发。
要点
- 术后[68Ga]Ga-DOTA-TATE PET/CT阳性与WHO 1级脑膜瘤进展风险增加相关(p=0.015)。
- PET阴性患者20/20(100%)在中位随访52个月内保持无复发。
- PET显示的肿瘤残余体积大于MRI(p=0.032)。
核心结论
- [68Ga]Ga-DOTA-TATE PET/CT在揭示WHO 1级脑膜瘤术后肿瘤残余方面具有高敏感性。
- PET阴性发现与更高的无进展生存期相关,从而改善监测。
- 对于存在肿瘤残余的患者,额外PET可优化手术切除脑膜瘤的辅助放疗靶区规划。
研究设计与样本
- 对前瞻性患者队列进行事后分析,纳入切除的WHO 1级脑膜瘤患者,术后接受MRI和[68Ga]Ga-DOTA-TATE PET/CT并定期MRI随访监测复发/进展。
- 共纳入46例患者49个肿瘤,诊断时平均年龄57.8±1.7岁,男女比1:1.7。
主要发现
- 中位随访52个月,7/49(14%)出现局部肿瘤进展。
- PET阳性与进展风险增加相关(p=0.015)且与无进展生存期降低相关(p=0.029),而MRI无此关联。
- PET阴性患者20/20(100%)保持无复发。
- MRI上复发/进展位置在所有病例中均邻近术后PET指示肿瘤残余的区域。
- PET上的肿瘤大体体积高于MRI(p=0.032)。
临床怎么用
- 术后[68Ga]Ga-DOTA-TATE PET/CT可用于揭示WHO 1级脑膜瘤患者的肿瘤残余。
- 对于存在肿瘤残余的患者,额外PET可优化辅助放疗靶区规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tumor resection represents the first-line treatment for symptomatic meningiomas, and the extent of resection has been shown to be of prognostic importance. Assessment of tumor remnants with somatostatin receptor PET proves to be superior to intraoperative estimation with Simpson grading or MRI. In this preliminary study, we evaluate the prognostic relevance of postoperative PET for progression-free survival in meningiomas. METHODS: We conducted a post hoc analysis on a prospective patient cohort with resected meningioma WHO grade 1. Patients received postoperative MRI and [68Ga]Ga-DOTA-TATE PET/CT and were followed regularly with MRI surveillance scans for detection of tumor recurrence/progression. RESULTS: We included 46 patients with 49 tumors. The mean age at diagnosis was 57.8 ± 1.7 years with a male-to-female ratio of 1:1.7. Local tumor progression occurred in 7/49 patients (14%) after a median follow-up of 52 months. Positive PET was associated with an increased risk for progression (*p = 0.015) and a lower progression-free survival (*p = 0.029), whereas MRI was not. 20 out of 20 patients (100%) with negative PET findings remained recurrence-free. The location of recurrence/progression on MRI was adjacent to regions where postoperative PET indicated tumor remnants in all cases. Gross tumor volumes were higher on PET compared to MRI (*p = 0.032). CONCLUSION: Our data show that [68Ga]Ga-DOTA-TATE PET/CT is highly sensitive in revealing tumor remnants in patients with meningioma WHO grade 1. Negative PET findings were associated with a higher progression-free survival, thus improving surveillance. In patients with tumor remnants, additional PET can optimize adjuvant radiotherapy target planning of surgically resected meningiomas.
引用
- Teske N, Biczok A, Quach S, et al. Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1. Eur J Nucl Med Mol Imaging. 2023. PMID: 37642702. doi:10.1007/s00259-023-06400-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。